Digital Tools to Expand COVID-19 Testing in Exposed Individuals in Cameroon
Launched by ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION · Jan 11, 2023
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
The study's general objective is to assess the effectiveness, feasibility, acceptability, and cost associated with the addition of a Mamal Pro digital contact tracing module to the Mamal Pro app in improving COVID-19 contact tracing and testing in Littoral, Cameroon.
Specific objectives are:
1. Primary objective: To determine the effectiveness of the use of a Mamal Pro digital contact tracing module added to the Mamal Pro app in improving COVID-19 contact tracing and testing compared to the SOC as measured by:
* The number and proportion of reported contacts who received SARS-CoV-2 te...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All contacts listed by individuals registered in the Mamal Pro app for testing, who test positive for SARS-CoV-2 in the selected health district testing units and health facilities in Cameroon.
- Exclusion Criteria:
- • None
About Elizabeth Glaser Pediatric Aids Foundation
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a leading nonprofit organization dedicated to eradicating pediatric HIV/AIDS through innovative research, comprehensive care, and advocacy. Founded in 1988, EGPAF focuses on improving the health and well-being of children and families affected by HIV/AIDS worldwide. Through its commitment to advancing scientific knowledge and implementing evidence-based interventions, the foundation plays a pivotal role in clinical trials aimed at developing effective treatments and prevention strategies. By collaborating with global health partners, EGPAF strives to ensure that every child has the opportunity to live a healthy, HIV-free life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Douala, Littoral, Cameroon
Patients applied
Trial Officials
Boris Tchakounte Youngui, MD, MPH
Principal Investigator
Elizabeth Glaser Pediatric AIDS Foundation
Godfrey Woelk, PhD, MCOMMH
Principal Investigator
Elizabeth Glaser Pediatric AIDS Foundation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials